Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Cash Flow PerformanceNormalizing
Percentile Rank86
3Y CAGR-4.1%
5Y CAGR+5.6%
Year-over-Year Change
Free cash flow yield
3Y CAGR
-4.1%/yr
vs +7.9%/yr prior
5Y CAGR
+5.6%/yr
Recent deceleration
Acceleration
-12.0pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.05% | +6.0% |
| 2024 | 4.77% | +21.8% |
| 2023 | 3.91% | -31.7% |
| 2022 | 5.73% | -41.5% |
| 2021 | 9.78% | +153.8% |
| 2020 | 3.85% | -21.0% |
| 2019 | 4.88% | +15.4% |
| 2018 | 4.23% | +78.0% |
| 2017 | 2.37% | +4.0% |
| 2016 | 2.28% | - |